« Back to Record
Citation APA

Manson, G., Brice, P., Herbaux, C., Silva, M., Bouabdallah, K., Deau, B., Bouteloup, J., Schiano, J. M., Nicolas-Virelizier, E., Maerevoet, M., Ghesquieres, H., Stamatoullas, A., Antier, C., Carlo-Stella, C., de Charette, M., Poizeau, F., Dercle, L., & Houot, R. (2021). Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 48, 4, (1144-1153), 10.1007/s00259-020-05015-2). European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-021-05321-3


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/321168

Manson, G., Brice, P., Herbaux, C., Silva, M., Bouabdallah, K., Deau, B., Bouteloup, J., Schiano, J. M., Nicolas-Virelizier, E., Maerevoet, M., Ghesquieres, H., Stamatoullas, A., Antier, C., Carlo-Stella, C., de Charette, M., Poizeau, F., Dercle, L., & Houot, R. (2021). Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 48, 4, (1144-1153), 10.1007/s00259-020-05015-2). European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-021-05321-3